来自MSN

2025乙肝治疗新曙光：浩博AHB-137临床试验揭盲在即

2025年治疗乙肝新药有最新消息啦！在全球数亿乙肝患者翘首以盼的目光中，乙肝治疗领域迎来了一束新的曙光。近日，浩博医药传来振奋人心的消息，其旗下自主研发用于慢性乙型肝炎治疗的反义寡核苷酸（ASO）疗法在研乙肝新药AHB-137取得重大进展：IIb期临床 ...
腾讯网

乙肝新药上市前冲刺？AHB-137 Ⅲ 期临床试验全国多机构启动，受试者 ...

根据国家药物临床试验登记与信息公示平台显示，AHB-137用于核苷（酸）类似物治疗的慢性乙型肝炎受试者的Ⅲ期临床试验，正在进行中，全国各参加机构陆续启动受试者招募。 AHB-137，是开发用于慢性乙型肝炎(CHB)治疗的一款反义寡核苷酸 (ASO) ，具有CHB临床治愈 ...
TechRepublic

Implementation of AMBA AHB Protocol for Wide Narrow BUS-SLAVE Combination Using VHDL

The Advanced Microcontroller Bus Architecture (AMBA) is an open System-on-Chip bus protocol for high-performance buses on low-power devices. In this paper, the authors implement a simple model of AMBA ...
Yahoo Finance

AusperBio Completes Enrollment in Two Phase II Clinical Trials of AHB-137 for Chronic ...

SAN FRANCISCO, Sept. 18, 2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted ...
EDN

Code verifies AHB designs

Advanced verification specialist EVE has selected silicon- and product-design-services company eInfochips to expand and complement the internally developed synthesizable transactor library for EVE's ...
Electronic Design

Interconnect IP Eases Data Management On SOCs

A just-released version of the SonicsMX SMART Interconnect from Sonics Inc. adds seamless connection and data-flow services management for intellectual property (IP) cores implemented using the ARM ...